MURRAY HILL, N.J.--(BUSINESS WIRE)--March 9, 2004--C. R. Bard,
Inc. (NYSE-BCR) today announced that it expects first quarter 2004
results to exceed prior guidance. The company now expects earnings per
share between $1.02 and $1.04 on a net sales increase in the range
between 8 and 11 percent in constant currency. In its fourth quarter
2003 earnings call, the company had indicated that it expected to earn
between $1.00 and $1.01 per share on a net sales increase of 8 percent
in constant currency.
Chairman and Chief Executive Officer, Timothy M. Ring, commented,
"We have entered into 2004 with some nice momentum and are pleased to
be experiencing a strong first quarter. Currently, our full-year
guidance remains unchanged."
C. R. Bard, Inc., (www.crbard.com) headquartered in Murray Hill,
N.J., is a leading multinational developer, manufacturer, and marketer
of innovative, life-enhancing medical technologies in the fields of
vascular, urology, oncology, and surgical specialty products.
This press release contains forward-looking statements, the
accuracy of which is necessarily subject to risks and uncertainties.
Please refer to our September 30, 2003 Form 10-Q for a statement with
regard to forward-looking statements, including disclosure of the
factors that could cause actual results to differ materially from
those expressed or implied.
CONTACT: C. R. Bard, Inc.
Eric J. Shick, 908-277-8413
Holly P. Glass, 703-754-2848
SOURCE: C. R. Bard, Inc.